Practice guidelines for the management of patients with sporotrichosis. For the Mycoses Study Group. Infectious Diseases Society of America.
about
In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phasesSynthesis of melanin-like pigments by Sporothrix schenckii in vitro and during mammalian infectionCat-transmitted sporotrichosis epidemic in Rio de Janeiro, Brazil: description of a series of casesClinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of AmericaCoinfection with HIV and tropical infectious diseases. II. Helminthic, fungal, bacterial, and viral pathogens.Genetic diversity and antifungal susceptibility profiles in causative agents of sporotrichosis.Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day(-1)) in the treatment of cutaneous or lymphocutaneous sporotrichosis.Fungal infections in older adults.A clinical perspective for the management of invasive fungal infections: focus on IDSA guidelines. Infectious Diseases Society of America.Sporotrichosis masquerading as pyoderma gangrenosum: case report and review of 19 cases of sporotrichosis.Sporotrichosis: an overview and therapeutic optionsApplication of 6-nitrocoumarin as a substrate for the fluorescent detection of nitroreductase activity in Sporothrix schenckiiCutaneous sporotrichosis treated with photodynamic therapy: an in vitro and in vivo study.In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methodsEvaluation and management of fungal infections in immunocompromised patients.A 27-Year-Old Severely Immunosuppressed Female with Misleading Clinical Features of Disseminated Cutaneous Sporotrichosis.Pharmacology and clinical use of voriconazole.Update on the optimal use of voriconazole for invasive fungal infections.Cutaneous sporotrichosis: a six-year review of 19 cases in a tertiary referral center in Malaysia.Pulmonary sporotrichosis: case series and systematic analysis of literature on clinico-radiological patterns and management outcomes.Clinical Characteristics, Diagnosis, Management, and Outcomes of Disseminated Emmonsiosis: A Retrospective Case Series.The antifungal pipeline: a reality check.In vitro susceptibilities of isolates of Sporothrix schenckii to itraconazole and terbinafine.In vitro antifungal susceptibilities of five species of sporothrixEfficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosisSporotrichosis, Plain of Jars, Lao People's Democratic RepublicSporothrix schenckii associated with armadillo hunting in Southern Brazil: epidemiological and antifungal susceptibility profiles.An epidemic of sporotrichosis in Rio de Janeiro, Brazil: epidemiological aspects of a series of cases.Potassium iodide remains the most effective therapy for cutaneous sporotrichosis.Paradoxical worsening of Emergomyces africanus infection in an HIV-infected male on itraconazole and antiretroviral therapy.Need for Alternative Trial Designs and Evaluation Strategies for Therapeutic Studies of Invasive Mycoses
P2860
Q24530443-48257A57-9BB6-4043-BE5D-20CB3FB1AD40Q24680336-C5A0DBFB-E32E-4026-A009-9CCEF93AE217Q28242627-818FE6F6-FFF3-4A49-9ABC-93C0D3FB245FQ28255282-6842E58B-5BFF-4604-AC8D-66A1955CA4D3Q30364999-41A0C17C-7A86-4A11-B315-F70B269FDCBAQ33611290-CB73CF64-0496-489A-B0A8-580A0D818978Q34302843-438E4DAA-B7FE-497F-B717-39BD40A200ADQ34312894-FBFB58CD-9723-42E7-AAC4-C3C12C45CA77Q34335250-EDE75717-2308-4CAD-8ECF-D7FA56F2337DQ34529509-88CCD74B-989B-4741-88B2-7E910290FD53Q34968193-37409BAE-144D-4758-B5E9-1BFC76FD2117Q34987510-D3BA7A5D-4A72-4637-B131-384B84AB7C9CQ35064883-E0F053FA-B98F-4DC2-9E97-368829816A5CQ35879091-57F5B065-43BD-421D-A315-07E79239E37AQ36103156-35FA0F82-A376-47FE-AC0F-40ACF6D43522Q36530121-3D62187D-06AC-4F1E-8D0D-5A9221502F81Q37641375-71947678-BBDE-4FED-B4CA-CF99E06B8799Q37892901-715A2316-9337-49B3-AFA3-A1D484ECED19Q38011244-5DFE5DEC-8FF4-4BCE-9FDB-1A6C6BF96426Q38071336-7009519F-C339-4757-B257-146CB77F0B75Q38523245-8A313F1C-02CE-45B7-86AA-61176F5C9AC6Q39299949-61BB51D3-59BF-4FAA-9510-5828D8C1DFF5Q39989865-A3EE0B85-58EA-478A-90B2-372BD0588E19Q41915091-9C6A9260-FB86-4D61-B371-CE4ED88A9491Q41931602-88B8CEA0-357E-45EF-BE03-4C66F05B159DQ42572366-7FB03BBE-C744-43E7-BCA4-9412200165E2Q42803387-6081A371-90AD-4E00-BE1A-AC4EFC0E14FEQ43355749-C80504AB-0687-4059-AFF0-3AA2654C58B2Q44049273-ABD1E136-83B0-4A37-AEB9-E56E0AF2889CQ53703714-57A4B3DE-7F95-4671-8971-930A9A75DC32Q56837353-D57EB65A-AAED-4A06-817E-7F576AA6B61A
P2860
Practice guidelines for the management of patients with sporotrichosis. For the Mycoses Study Group. Infectious Diseases Society of America.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Practice guidelines for the ma ...... s Diseases Society of America.
@en
Practice guidelines for the ma ...... s Diseases Society of America.
@nl
type
label
Practice guidelines for the ma ...... s Diseases Society of America.
@en
Practice guidelines for the ma ...... s Diseases Society of America.
@nl
prefLabel
Practice guidelines for the ma ...... s Diseases Society of America.
@en
Practice guidelines for the ma ...... s Diseases Society of America.
@nl
P2093
P2860
P356
P1476
Practice guidelines for the ma ...... s Diseases Society of America.
@en
P2093
P2860
P304
P356
10.1086/313751
P407
P577
2000-04-20T00:00:00Z